The United Kingdom stands on the threshold of a radical transformation in obesity treatment, as Eli Lilly prepares to introduce a daily weight-loss pill, Orforglipron, in 2026, once regulatory approval
All posts tagged in obesity treatment
7Articles
Eli Lilly, the US manufacturer of the weight management injection Mounjaro, has announced a new discount for private pharmacies in the UK. The move follows widespread concern after the company
A new oral medication weight loss, orforglipron, has shown promising results in a landmark trial, marking a significant step for obesity treatment in the UK. Developed by Eli Lilly, orforglipron
Danish pharmaceutical giant Novo Nordisk has projected reduced growth for 2025 amidst mounting competition in the weight-loss drugs market from American rivals. The company, renowned for its obesity treatments Ozempic
The United Kingdom’s weight-loss medication market has witnessed an unprecedented surge, with more than 500,000 individuals now utilising revolutionary anti-obesity drugs Mounjaro and Wegovy. This dramatic increase has occurred within
Danish pharmaceutical giant Novo Nordisk has reported exceptional third-quarter results, driven by remarkable sales of its weight-loss treatment Wegovy. The anti-obesity medication generated sales of 17.3 billion Danish krone (£1.96
In a remarkable feat, Eli Lilly’s weight-loss drug Zepbound has surpassed 1 billion in sales for the first time, exceeding Wall Street’s expectations. The American pharmaceutical giant also saw strong
